Work

Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib

Year: 2017

Type: article

Source: Cancer Investigation

DOI: 10.1080/07357907.2017.1340479

Authors: Shing M. Lee, Yuan Zhang, Lori M. Minasian, Joseph M. Unger, Dawn L. Hershman

Institutions: Columbia University, National Institutes of Health, National Cancer Institute, Fred Hutch Cancer Center, Herbert Irving Comprehensive Cancer Center

Language: English

Topic: Statistical Methods in Clinical Trials

Subfield: Statistics and Probability

Field: Mathematics

Domain: Physical Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2735569446

FWCI: 0.377

Cites: 14

Cited by: 3

Related to: 10